Future Medicine Ltd., part of Future Science Group, UK, has announced a further addition to its journal portfolio with the launch of a new bimonthly title, Breast Cancer Management. The journal seeks to provide a rapid-publication platform for debate and the presentation of new findings in the field of breast cancer treatment.
Breast Cancer Management addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy.
The Editorial Board comprises global opinion leaders in breast cancer research and clinical practice, selected specifically to ensure a balanced range of expertise that covers all clinical disciplines, as well as translational researchers involved in breast cancer management. Senior Editors V. Craig Jordan from Georgetown University Medical Center, US, and Mike Dixon from University of Edinburgh, UK, are supported by two Associate Editors, together with an Advisory Panel of 26 international experts.
The editorial office is now actively soliciting contributions of reviews, perspectives and editorial articles for the journal.
